These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 8827076)

  • 61. Novel deletion in 11p15.5 imprinting center region 1 in a patient with Beckwith-Wiedemann syndrome provides insight into distal enhancer regulation and tumorigenesis.
    Bachmann N; Crazzolara R; Bohne F; Kotzot D; Maurer K; Enklaar T; Prawitt D; Bergmann C
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650505
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epigenetic differences between Wilms' tumours in white and east-Asian children.
    Fukuzawa R; Breslow NE; Morison IM; Dwyer P; Kusafuka T; Kobayashi Y; Becroft DM; Beckwith JB; Perlman EJ; Reeve AE
    Lancet; 2004 Feb; 363(9407):446-51. PubMed ID: 14962525
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A novel IGF2/H19 domain triplication in the 11p15.5 imprinting region causing either Beckwith-Wiedemann or Silver-Russell syndrome in a single family.
    Jurkiewicz D; Kugaudo M; Skórka A; Śmigiel R; Smyk M; Ciara E; Chrzanowska K; Krajewska-Walasek M
    Am J Med Genet A; 2017 Jan; 173(1):72-78. PubMed ID: 27612309
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma.
    el-Naggar AK; Lai S; Tucker SA; Clayman GL; Goepfert H; Hong WK; Huff V
    Oncogene; 1999 Nov; 18(50):7063-9. PubMed ID: 10597307
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IGF2 but not H19 shows loss of imprinting in human glioma.
    Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
    Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor.
    Thompson JS; Reese KJ; DeBaun MR; Perlman EJ; Feinberg AP
    Cancer Res; 1996 Dec; 56(24):5723-7. PubMed ID: 8971182
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain.
    Reik W; Brown KW; Schneid H; Le Bouc Y; Bickmore W; Maher ER
    Hum Mol Genet; 1995 Dec; 4(12):2379-85. PubMed ID: 8634713
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer.
    Murrell A; Ito Y; Verde G; Huddleston J; Woodfine K; Silengo MC; Spreafico F; Perotti D; De Crescenzo A; Sparago A; Cerrato F; Riccio A
    PLoS One; 2008 Mar; 3(3):e1849. PubMed ID: 18365005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Imprinting in clusters: lessons from Beckwith-Wiedemann syndrome.
    Reik W; Maher ER
    Trends Genet; 1997 Aug; 13(8):330-4. PubMed ID: 9260520
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
    Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
    Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma.
    Kim KS; Lee YI
    Cancer Lett; 1997 Nov; 119(2):143-8. PubMed ID: 9570364
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
    Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
    J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19.
    Hu JF; Vu TH; Hoffman AR
    J Biol Chem; 1997 Aug; 272(33):20715-20. PubMed ID: 9252392
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Malignant melanoma and Wiedemann-Beckwith syndrome in childhood.
    Livingstone E; Caliebe A; Egberts F; Proksch E; Buiting K; Schubert C; Claviez A; Siebert R; Hauschild A
    Klin Padiatr; 2010 Nov; 222(6):388-90. PubMed ID: 21058226
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Perinatal lethality in H19 enhancers-Igf2 transgenic mice.
    Wise TL; Pravatcheva DD
    Mol Reprod Dev; 1997 Oct; 48(2):194-207. PubMed ID: 9291469
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Decreased expression of p57(KIP2)mRNA in human bladder cancer.
    Oya M; Schulz WA
    Br J Cancer; 2000 Sep; 83(5):626-31. PubMed ID: 10944603
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors.
    Newsham I; Kindler-Röhrborn A; Daub D; Cavenee W
    Genes Chromosomes Cancer; 1995 Jan; 12(1):1-7. PubMed ID: 7534105
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
    Mummert SK; Lobanenkov VA; Feinberg AP
    Genes Chromosomes Cancer; 2005 Jun; 43(2):155-61. PubMed ID: 15761865
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Beckwith-Wiedemann syndrome.
    Choufani S; Shuman C; Weksberg R
    Am J Med Genet C Semin Med Genet; 2010 Aug; 154C(3):343-54. PubMed ID: 20803657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.